Literature DB >> 15282410

Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1.

Jason M Hansen1, Walter H Watson, Dean P Jones.   

Abstract

Nrf-2 is a redox-sensitive transcription factor that is activated by an oxidative signal in the cytoplasm but has a critical cysteine that must be reduced to bind to DNA in the nucleus. The glutathione (GSH) and thioredoxin (TRX) systems have overlapping functions in thiol/disulfide redox control in both the cytoplasm and the nucleus, and it is unclear whether these are redundant or have unique functions in control of Nrf-2-dependent signaling. To test whether GSH and Trx-1 have distinct functions in Nrf-2 signaling, we selectively modified GSH by metabolic manipulation and selectively modified Trx-1 expression by transient transfection. Cytoplasmic activation of Nrf-2 was measured by its nuclear translocation and nuclear activity of Nrf-2 was measured by expression of a luciferase reporter construct containing an ARE4 from glutamate cysteine ligase. Results showed that tert-butylhydroquinone (TBHQ), a transcriptional activator that functions through Nrf-2/ARE, promoted Nrf-2 nuclear translocation by a type I (thiylation) redox switch which was regulated by GSH not by Trx-1. In contrast, the ARE reporter was principally controlled by nuclear-targeted Trx-1 and not by GSH. The data show that the GSH and TRX systems have unique, compartmented functions in the control of transcriptional regulation by Nrf-2/ARE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282410     DOI: 10.1093/toxsci/kfh231

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  65 in total

Review 1.  Molecular mechanisms of Nrf2-mediated antioxidant response.

Authors:  Wenge Li; Ah-Ng Kong
Journal:  Mol Carcinog       Date:  2009-02       Impact factor: 4.784

Review 2.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 3.  Mitochondrial ROS control of cancer.

Authors:  María Del Pilar Sosa Idelchik; Ulrike Begley; Thomas J Begley; J Andrés Melendez
Journal:  Semin Cancer Biol       Date:  2017-04-23       Impact factor: 15.707

Review 4.  Nuclear Factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in Atherosclerosis and Ischemia/Reperfusion Injury in the Heart.

Authors:  Philipp Jakobs; Vlad Serbulea; Norbert Leitinger; Anna Eckers; Judith Haendeler
Journal:  Antioxid Redox Signal       Date:  2017-01-18       Impact factor: 8.401

Review 5.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

Review 6.  Redox control systems in the nucleus: mechanisms and functions.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Antioxid Redox Signal       Date:  2010-08-15       Impact factor: 8.401

Review 7.  Regulation of cell survival and death by pyridine nucleotides.

Authors:  Shin-Ichi Oka; Chiao-Po Hsu; Junichi Sadoshima
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

Review 8.  Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology.

Authors:  Melissa Kemp; Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2007-11-28       Impact factor: 7.376

9.  Generation of double-labeled reporter cell lines for studying co-dynamics of endogenous proteins in individual human cells.

Authors:  Irina Issaeva; Ariel A Cohen; Eran Eden; Cellina Cohen-Saidon; Tamar Danon; Lydia Cohen; Uri Alon
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

10.  Hydrogen peroxide is a second messenger in phase 2 enzyme induction by cancer chemopreventive dithiolethiones.

Authors:  Ryan Holland; Mettachit Navamal; Murugesan Velayutham; Jay L Zweier; Thomas W Kensler; James C Fishbein
Journal:  Chem Res Toxicol       Date:  2009-08       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.